FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034609501> ?p ?o ?g. }

• W2034609501 endingPage "2263" @default.
• W2034609501 startingPage "2259" @default.
• W2034609501 abstract "The bone mass benefits of antiresorbers in postmenopausal osteoporosis are limited by the rapid coupling of decreasing bone resorption with bone formation. Wnt signaling is involved in this coupling process during treatment with bisphosphonates, whereas its role during treatment with the anti-receptor activator of NF-κB ligand (RANKL) antibody denosumab is unknown. The study population includes patients participating in a placebo-controlled trial lasting 36 months: 19 women were on placebo and 24 on subcutaneous 60 mg denosumab every 6 months. All measured parameters (serum C-terminal telopeptide of type I collagen [sCTX], serum bone alkaline phosphatase [bAP], Dickkopf-1 [DKK1], and sclerostin) remained unchanged during the observation period in the placebo group. sCTX and bAP were significantly suppressed by denosumab treatment over the entire follow-up. Denosumab treatment was associated with significant (p < 0.05) increases (28% to 32%) in serum sclerostin over the entire study follow-up. Serum DKK1 significantly decreased within the first 6 months with a trend for further continuous decreases, which reached statistical significance (p < 0.05) versus placebo group from the 18th month onward. The changes in DKK1 were significantly and positively related with the changes in sCTX and bAP and negatively with hip bone mineral density (BMD) changes. The changes in sclerostin were significantly and negatively related only with those of bAP. The changes in bone turnover markers associated with denosumab treatment of postmenopausal osteoporosis is associated with significant increase in sclerostin similar to those seen after long-term treatment with bisphosphonates and significant decrease in DKK1. This latter observation might explain the continuous increase over 5 years in BMD observed during treatment of postmenopausal osteoporosis with denosumab. © 2012 American Society for Bone and Mineral Research." @default.
• W2034609501 created "2016-06-24" @default.
• W2034609501 creator A5011399435 @default.
• W2034609501 creator A5013752581 @default.
• W2034609501 creator A5026470430 @default.
• W2034609501 creator A5038627121 @default.
• W2034609501 creator A5045315263 @default.
• W2034609501 creator A5057958762 @default.
• W2034609501 creator A5058144305 @default.
• W2034609501 creator A5071359531 @default.
• W2034609501 date "2012-10-16" @default.
• W2034609501 modified "2023-10-15" @default.
• W2034609501 title "Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab" @default.
• W2034609501 cites W1944559787 @default.
• W2034609501 cites W1964066819 @default.
• W2034609501 cites W1970864109 @default.
• W2034609501 cites W1975123703 @default.
• W2034609501 cites W1985645291 @default.
• W2034609501 cites W1995251672 @default.
• W2034609501 cites W1996161852 @default.
• W2034609501 cites W2002725330 @default.
• W2034609501 cites W2022112190 @default.
• W2034609501 cites W2023331229 @default.
• W2034609501 cites W2028914771 @default.
• W2034609501 cites W2029674033 @default.
• W2034609501 cites W2037927763 @default.
• W2034609501 cites W2038733673 @default.
• W2034609501 cites W2039215669 @default.
• W2034609501 cites W2044068623 @default.
• W2034609501 cites W2044212277 @default.
• W2034609501 cites W2048299560 @default.
• W2034609501 cites W2051748491 @default.
• W2034609501 cites W2064569180 @default.
• W2034609501 cites W2065843550 @default.
• W2034609501 cites W2087578607 @default.
• W2034609501 cites W2088466503 @default.
• W2034609501 cites W2091664518 @default.
• W2034609501 cites W2091844812 @default.
• W2034609501 cites W2131321005 @default.
• W2034609501 cites W2149719379 @default.
• W2034609501 cites W2160005424 @default.
• W2034609501 cites W2160664367 @default.
• W2034609501 cites W4254761345 @default.
• W2034609501 doi "https://doi.org/10.1002/jbmr.1681" @default.
• W2034609501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22692843" @default.
• W2034609501 hasPublicationYear "2012" @default.
• W2034609501 type Work @default.
• W2034609501 sameAs 2034609501 @default.
• W2034609501 citedByCount "89" @default.
• W2034609501 countsByYear W20346095012013 @default.
• W2034609501 countsByYear W20346095012014 @default.
• W2034609501 countsByYear W20346095012015 @default.
• W2034609501 countsByYear W20346095012016 @default.
• W2034609501 countsByYear W20346095012017 @default.
• W2034609501 countsByYear W20346095012018 @default.
• W2034609501 countsByYear W20346095012019 @default.
• W2034609501 countsByYear W20346095012020 @default.
• W2034609501 countsByYear W20346095012021 @default.
• W2034609501 countsByYear W20346095012022 @default.
• W2034609501 countsByYear W20346095012023 @default.
• W2034609501 crossrefType "journal-article" @default.
• W2034609501 hasAuthorship W2034609501A5011399435 @default.
• W2034609501 hasAuthorship W2034609501A5013752581 @default.
• W2034609501 hasAuthorship W2034609501A5026470430 @default.
• W2034609501 hasAuthorship W2034609501A5038627121 @default.
• W2034609501 hasAuthorship W2034609501A5045315263 @default.
• W2034609501 hasAuthorship W2034609501A5057958762 @default.
• W2034609501 hasAuthorship W2034609501A5058144305 @default.
• W2034609501 hasAuthorship W2034609501A5071359531 @default.
• W2034609501 hasBestOaLocation W20346095011 @default.
• W2034609501 hasConcept C104317684 @default.
• W2034609501 hasConcept C125870589 @default.
• W2034609501 hasConcept C126322002 @default.
• W2034609501 hasConcept C131075544 @default.
• W2034609501 hasConcept C134018914 @default.
• W2034609501 hasConcept C137620995 @default.
• W2034609501 hasConcept C142724271 @default.
• W2034609501 hasConcept C160160445 @default.
• W2034609501 hasConcept C170033053 @default.
• W2034609501 hasConcept C170493617 @default.
• W2034609501 hasConcept C181199279 @default.
• W2034609501 hasConcept C185592680 @default.
• W2034609501 hasConcept C204787440 @default.
• W2034609501 hasConcept C27081682 @default.
• W2034609501 hasConcept C2776286101 @default.
• W2034609501 hasConcept C2776541429 @default.
• W2034609501 hasConcept C2776886416 @default.
• W2034609501 hasConcept C2777491412 @default.
• W2034609501 hasConcept C2779277721 @default.
• W2034609501 hasConcept C2779428903 @default.
• W2034609501 hasConcept C55493867 @default.
• W2034609501 hasConcept C673006 @default.
• W2034609501 hasConcept C71924100 @default.
• W2034609501 hasConcept C88045685 @default.
• W2034609501 hasConceptScore W2034609501C104317684 @default.
• W2034609501 hasConceptScore W2034609501C125870589 @default.
• W2034609501 hasConceptScore W2034609501C126322002 @default.
• W2034609501 hasConceptScore W2034609501C131075544 @default.

• next